Cordyceps Sunshine Biotech Holdings (RAJAF) Operating Leases (2020 - 2024)

Cordyceps Sunshine Biotech Holdings' Operating Leases history runs 5 years deep, the most recent figure standing at $12602.0 for Q4 2024.

• In Q4 2024, Operating Leases fell 88.15% year-over-year to $12602.0; the TTM figure through Dec 2024 stood at $12602.0 (down 88.15% YoY), while the FY2024 annual figure was $12602.0, down 88.15% from the prior year.
• Operating Leases was $12602.0 for Q4 2024 at Cordyceps Sunshine Biotech Holdings, down from $106356.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $203325.0 in Q4 2021 to a low of $11056.0 in Q4 2020.
• Historically, Operating Leases has averaged $92620.8 across 5 years, with a median of $103842.5 in 2023.
• The sharpest annual moves came in 2021 and 2024: Operating Leases jumped 1739.05% in 2021, then sank 88.15% in 2024.
• A 5-year view of Operating Leases shows it stood at $11056.0 in 2020, then surged by 1739.05% to $203325.0 in 2021, then sank by 40.46% to $121057.0 in 2022, then declined by 12.14% to $106356.0 in 2023, then tumbled by 88.15% to $12602.0 in 2024.
• The last three Operating Leases figures came in at $12602.0 (Q4 2024), $106356.0 (Q4 2023), and $101329.0 (Q3 2023), per Business Quant data.